Australia markets closed

Johnson & Johnson (JNJ)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
162.59+2.15 (+1.34%)
At close: 4:00PM EST

164.95 +2.36 (1.45%)
Pre-market: 6:29AM EST

Show:
Income statement
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Total revenue
82,584,000
82,584,000
82,059,000
81,581,000
76,450,000
Cost of revenue
28,427,000
28,427,000
27,556,000
27,091,000
25,354,000
Gross profit
54,157,000
54,157,000
54,503,000
54,490,000
51,096,000
Operating expenses
Research development
12,159,000
12,159,000
11,355,000
10,775,000
10,554,000
Selling general and administrative
22,084,000
22,084,000
22,178,000
22,540,000
21,420,000
Total operating expenses
34,243,000
34,243,000
33,533,000
33,315,000
31,974,000
Operating income or loss
19,914,000
19,914,000
20,970,000
21,175,000
19,122,000
Interest expense
201,000
201,000
318,000
1,005,000
934,000
Total other income/expenses net
-3,327,000
-3,327,000
-3,681,000
-2,782,000
-900,000
Income before tax
16,497,000
16,497,000
17,328,000
17,999,000
17,673,000
Income tax expense
1,783,000
1,783,000
2,209,000
2,702,000
16,373,000
Income from continuing operations
14,714,000
14,714,000
15,119,000
15,297,000
1,300,000
Net income
14,714,000
14,714,000
15,119,000
15,297,000
1,300,000
Net income available to common shareholders
14,714,000
14,714,000
15,119,000
15,297,000
1,300,000
Basic EPS
-
-
5.72
5.70
0.48
Diluted EPS
-
-
5.63
5.61
0.47
Basic average shares
-
-
2,645,100
2,681,500
2,692,000
Diluted average shares
-
-
2,684,300
2,728,700
2,745,300
EBITDA
-
23,929,000
24,655,000
25,933,000
24,249,000